Previous Close | 1.87 |
1-Year Change | -80.68% |
6-Months Change | -48.63% |
3-Months Change | 19.11% |
Moving Avg (50d) | 1.653 |
Moving Avg (200d) | 3.8401 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 483.2M |
Beta (3-Years) | 2.7 |
Revenue Growth (ttm) | 23.76% |
Net Profit Margin (ttm) | -182.34% |
Return On Assets (ttm) | -16.28% |
EPS (ttm) | -1.27 |
PE Ratio (ttm) | -1.47 |
Dividend Yield | % |
Asset Description: | Pacific Biosciences of California, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-09-09 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
1.833 | 1.777 | 1.739 | 1.683 | 1.59 | 1.496 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.